PKCβ inhibitor 1

TargetMol
Product Code: TAR-T8376
Supplier: TargetMol
CodeSizePrice
TAR-T8376-1mg1mg£252.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-2mg2mg£354.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-5mg5mg£565.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-1mL1 mL * 10 mM (in DMSO)£629.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-10mg10mg£775.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-25mg25mg£1,131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-50mg50mg£1,508.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8376-100mg100mg£1,990.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
PKCβ inhibitor 1(KUN79359) is a potent, selective and ATP-competitive inhibitor of PKC isozymes(IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2, respectively).
CAS:
257879-35-9
Formula:
C24H21N5O2
Molecular Weight:
411.465
Pathway:
Apoptosis; Cytoskeletal Signaling; Chromatin/Epigenetic
Purity:
1
SMILES:
O=C1NC(=O)C(=C1Nc1ccccc1)c1cn(CCCn2ccnc2)c2ccccc12
Target:
Apoptosis; PKC

References

Saba N S , Levy L S . Protein Kinase C-Beta Inhibition Induces Apoptosis and Inhibits Cell Cycle Progression in Acquired Immunodeficiency Syndrome?Related Non-Hodgkin Lymphoma Cells[J]. Journal of Investigative Medicine, 2012, 60(1):29-. Nikolai, Pakhomov, Ksenia,et al. Negative inotropic effects of diadenosine tetraphosphate are mediated by protein kinase C and phosphodiesterases stimulation in the rat heart[J]. European Journal of Pharmacology An International Journal, 2018. Masahiro Tanaka, Shoichi Sagawa, Jun-ichi Hoshi,et al. Synthesis of anilino-monoindolylmaleimides as potent and selective PKC? inhibitors[J]. Bioorganic & Medicinal Chemistry Letters, 2004, 14(20):5171-5174.